Publisher's Synopsis
David Roy, a very sick man, is a participant in a trial for a promising new drug that may finally relieve his years of suffering. Just weeks into the testing, the trial is abruptly stopped by the drug's maker, Freiz pharmaceuticals, not because it isn't working, but rather because it appears to be working too well. David Roy along with Gina Coletti and Michael Fitzgerald, two employees of the company administering the trial who have become suspicious of their employer's motives, join together in their search for the truth. They are shocked and outraged by what they discover and are determined to expose the ruse. Freiz learns of their quest and is equally determined to stop them at any cost, resulting in political blackmail, murder and breakneck cat and mouse action that takes the reader to an unexpected and thrilling conclusion.
"Roy Eaton and Joseph DiLalla have delivered a taut, suspenseful narrative that plays off our deepest fears: loss, betrayal, and death. The reader is catapulted headlong into a drama that poses ethical dilemmas at every turn. The ending will surprise you." -David Farrar, Captain USN
"How fortunate we would be if the lives of those with artery disease were able to benefit from a curable therapy such as the apoA-1 Sicilia protein eliminating years of distressed health, restricted activities, and tragic deaths. As a health care provider, and daughter whose father never made it off the operating table from an open heart bypass surgery and whose mother-in-law suffered repeated heart attacks that crippled her through a long and agonizing life, I would consider withholding such a 'wonder drug' an unconscionable act toward mankind." -Beverly Ann Gentile Shipe, NP, RN
"This is a gem of a book, a real thriller. Although the book is fictional, the message it portrays is quite plausible. Great read!" -Geoff Bryant, President, Global Discount Prescriptions
